Endocrine regulation of energy metabolism: Review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin

Clinical Chemistry

Volumn 50, Issue 9, 2004, Pages 1511-1525

  Meier, Ursula ^a   Gressner, Axel M ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GHRELIN; LEPTIN; LEPTIN RECEPTOR; RESISTIN;

ADIPOSE TISSUE; APPETITE; ATHEROSCLEROSIS; BRAIN; CARDIOVASCULAR FUNCTION; CLINICAL CHEMISTRY; ENERGY BALANCE; ENERGY METABOLISM; GLUCOSE METABOLISM; HOMEOSTASIS AND REGULATION; HUMAN; IMMUNITY; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; LIVER FIBROSIS; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL STATUS; OBESITY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REPRODUCTION; REVIEW; SKELETAL MUSCLE; STOMACH;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; ENERGY METABOLISM; HORMONES, ECTOPIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; LIVER; MUSCLE, SKELETAL; OBESITY; PEPTIDE HORMONES; PROTEINS; RECEPTORS, CELL SURFACE; RESISTIN; STOMACH;

EID: 4344607526     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.032482     Document Type: Review

References (136)

1. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998;22:763-70.
2. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32.
3. Baratta M. Leptin - from a signal of adiposity to a hormone mediator in peripheral tissues. Med Sci Monit 2002;8:RA282-92.
4. Webber J. Energy balance in obesity. Proc Nutr Soc 2003;62: 539-43.
5. Tsiotra PC, Pappa V, Raphis SA, Tsigos C. Expression of the long and short leptin receptor isoforms in peripheral blood mononuclear cells: implications for leptin's actions. Metabolism 2000; 49:1537-41.
6. Trayhurn P, Hoggard N, Mercer JG, Rayner DV. Leptin: fundamental aspects. Int J Obes Relat Metab Disord 1999;23:22-8.
7. Lammert A, Kiess W, Bottner A, Glasow A, Kratzsch J. Soluble leptin receptor represents the main leptin binding activity in human blood. Biochem Biophys Res Commun 2001;283:982-8.
8. Wallace AM. Measurement of leptin and leptin binding in the human circulation. Ann Clin Biochem 2000;37:244-52.
9. Funahashi H, Yada T, Suzuki R, Shioda S. Distribution, function, and properties of leptin receptors in the brain. Int Rev Cytol 2003;224:1-27.
10. Rosicka M, Krsek M, Matoulek M, Jarkovska Z, Marek J, Justova V, et al. Serum ghrelin levels in obese patients: the relationship to serum leptin levels and soluble leptin receptor levels. Physiol Res 2003;52:61-6.
11. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 1999;282:1568-75.
12. El-Haschimi K, Pierroz DD, Hileman SM, Bjorback C, Flier JS. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity, J Clin Invest 2000;105:1827-32.
13. Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002;26:1407-33.
14. Veniant MM, LeBel CP. Leptin: from animals to humans. Curr Pharm Des 2003;9:811-8.
15. Chehab FF, Qiu J, Mounzih K, Ewart-Toland A, Ogus S. Leptin and reproduction. Nutr Rev 2002;60:S39-46, discussion S68-84, 85-7.
16. Magni P. Hormonal control of the neuropeptide Y system. Curr Protein Pept Sci 2003;4:45-57.
17. Sainsbury A, Cooney GJ, Herzog H. Hypothalamic regulation of energy homeostasis. Best Pract Res Clin Endocrinol Metab 2002;16:623-7.
18. Chan YY, Clifton DK, Steiner RA. Role of NPY neurones in GH-dependent feedback signalling to the brain. Horm Res 1996; 145:12-4.
19. Pierroz DD, Aebi AC, Huhtaniemi IT, Aubert ML. Many LH peaks are needed to physiologically stimulate testosterone secretion: modulation by fasting and NPY. Am J Physiol 1999;276:E603-10.
20. Rohner-Jeanrenaud F. Aspects of the neuroendocrine regulation of body weight homeostasis. Am Endocrinol 2002;63:125-8.
21. Shirasaka T, Takasaki M, Kannan H. Cardiovascular effects of leptin and orexins. Am J Physiol Regul lntegr Comp Physiol 2003;284:R639-51.
22. Hall JE, Crook ED, Jones DW, Wofford MR, Dubbert PM. Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci 2002;324:127-37.
23. Speakman JR, Stubbs RJ, Mercer JG. Does body mass play a role in the regulation of food intake? Proc Nutr Soc 2002;61:473-87.
24. Frayn KN, Karpe F, Fielding BA, Macdonald IA, Coppack SW. Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord 2003;27:875-88.
25. Koutkia P, Canavan B, Johnson ML, DePaoli A, Grinspoon S. Characterization of leptin pulse dynamics and relationship to fat mass, growth hormone, cortisol, and insulin. Am J Physiol Endocrinol Metab 2003;285:E372-9.
26. Leibel RL. The role of leptin in the control of body weight. Nutr Rev 2002;60:315-9, discussion S68-84, 85-7.
27. Slieker LJ, Sloop KW, Surface PL, Kriauciunas A, LaQuier F, Manetta J, et al. Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem 1996;271: 5301-4.
28. French S, Castiglione K. Recent advances in the physiology of eating. Proc Nutr Soc 2002;61:489-96.
29. Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med 2002;346:570-8.
30. Dötsch J, Meissner U, Rascher W. Leptin-induced weight loss is not solely mediated by anorexia. Eur J Endocrinol 2003;148:11-2.
31. Zabeau L, Lavens D, Peelman F, Eyckerman S, Vandekerckhove J, Tavernier J. The ins and outs of leptin receptor activation. FEBS Lett 2003;546:45-50.
32. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996;274:1185-8.
33. Tartaglia LA, Dembski M, Weng X, Deng W, Culpepper J, Devos R, et al. Identification and expression cloning of a leptin receptor, 0B-R. Cell 1995;83:1263-71.
34. Hileman SM, Pierroz DD, Masuzaki H, Bjorback C, El-Haschimi K, Banks WA, et al. Characterization of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity. Endocrinology 2002;143:775-83.
35. Hileman SM, Tornoe J, Flier JS, Bjorback C. Transcellular transport of leptin by the short leptin receptor isoform ObRa in Madin-Darby canine kidney cells. Endocrinology 2000;141:1955-61.
36. Ge HF, Huang L, Pourbahram T, Li C. Generation of soluble leptin receptor by ectodomain shedding of membrane-spanning receptors in vitro and in vivo. J Biol Chem 2002;277:45898-903.
37. Huang L, Wang Z, Li C. Modulation of circulating leptin levels by its soluble receptor. J Biol Chem 2001;276:6343-9.
38. Sinha MK, Ohannesian JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin S, et al. nocturnal rise of leptin in lean, obese, and non-insulin dependent diabetes mellitus subjects. J Clin Invest 1996;97:1344-7.
39. Pischon T, Hotamisligil GS, Rimm E. Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. Clin Chem 2003;49:650-2.
40. Holtkamp K, Herpertz-Dahlmann B, Mika C, Heer M, Heussen N, Fichter M, et al. Elevated physical activity and low leptin levels co-occur in patients with anorexia nervosa. J Clin Endocrinol Metab 2003;88:5169-74.
41. Krizova J, Sulkova S, Bednarova V, Kotrilikova E, Haluzik M. Soluble leptin receptor levels in patients with anorexia nervosa. Endocr Res 2002;28:199-205.
42. Haluzik M, Fiedler J, Nedvidkova J, Ceska R. Serum leptin levels in patients with hyperlipidemias. Nutrition 2000;16:429-33.
43. Blum WF, Juul A. Reference ranges of serum leptin. In: Blum WF, et al., eds. Leptin - the voice of adipose tissue. Heidelberg: Johann Ambrosius Verlag, 1997:318-26.
44. Gale SM, Castracane VD, Mantzoros CS. Energy homeostasis, obesity and eating disorders: recent advances in endocrinology. J Nutr 2004;134:295-8.
45. Radic R, Nikolic V, Karner I, Kosovic P, Kurbel S, Selthofer R, et al. Circadian rhythm of blood leptin in obese and non-obese people. Coll Antropol 2003;27:555-61.
46. Wong ML, Licinio J, Yildiz BO, Mantzoros CS, Prolo P, Kling M, et al. Simultaneous and continuous 24-hour plasma and cerebrospinal fluid leptin measurements: dissociation of concentrations in central and peripheral compartments. J Clin Endocrinol Metab 2004;89:258-65.
47. Kurrimbux D, Gaffen Z, Farrell CL, Martin D, Thomas SA. The involvement of the blood-brain and the blood-cerebrospinal fluid barriers in the distribution of leptin into and out of the rat brain. Neuroscience 2004;123:527-36.
48. Jequier E. Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci 2002;967:379-88.
49. Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004; 53(Suppl 1):S143-51.
50. Sandhofer A, Laimer M, Ebenbichler CF, Kaser S, Paulweber B, Patsch JR. Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome. Obes Res 2003; 11:760-8.
51. Schulze PC, Kratzsch J, Linke A, Schoene N, Adams V, Gielen S, et al. Elevated serum levels of leptin and leptin receptor in patients with advanced chronic heart failure. Eur J Heart Fail 2003;5:33-40.
52. Piche T, Vandenbos F, Abakar-Mahamat A, Vanbiervliet G, Barjoan EM, Calle G, et al. The severity of liver fibrosis is associated with high leptin levels in chronic hepatitis C. J Viral Hepat 2004;11:91-6.
53. Otte C, Otte JM, Strodthoff D, Bornstein SR, Folsch UR, Monig H, et al. Expression of leptin and leptin receptor during the development of liver fibrosis and cirrhosis. Exp Clin Endocrinol Diabetes 2004;112:10-7.
54. Hosoda H, Kojima M, Mitzushima T, Shimizu S, Kangawa K. Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by posttranslational processing. J Biol Chem 2003;278:67-70.
55. Kojima M, Hosoda H, Date Y. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402: 656-60.
56. Casanueva FF, Dieguez C. Ghrelin: the link connecting growth with metabolism and energy homeostasis. Rev Endocrinol Metab Disord 2002;3:326-38.
57. Petersenn S. Structure and regulation of the growth hormone secretagogue receptor. Minerva Endocrinol 2002;27:243-56.
58. Hagemann D, Meier JJ, Gallwitz B, Schmidt WE. Appetite regulation by ghrelin - a novel neuro-endocrine gastric peptide hormone in the gut-brain-axis [Review]. Z Gastroenterol 2003;41: 929-36.
59. Wang G, Lee HM, Englander E, Greeley GH Jr. Ghrelin - not just another stomach hormone. Regul Pept 2002;105:75-81.
60. Lazarczyk MA, Lazarczyk M, Grzela T. Ghrelin: a recently discovered gut-brain peptide. Int J Mol Med 2003;12:279-87.
61. Kojima M, Kangawa K. Ghrelin, an orexigenic signaling molecule from the gastrointestinal tract. Curr Opin Pharmacol 2002;2: 665-8.
62. Muccioli G, Tschöp M, Papotti M, Dghenghi R, Heiman M, Ghigo E. Neurodendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol 2002;440: 235-54.
63. Drazen DL, Woods SC. Peripheral signals in the control of satiety and hunger. Curr Opin Clin Nutr Metab Care 2003;6:621-9.
64. Gualillo O, Lago F, Gomez-Reino J, Casanueva FF, Dieguez C. Ghrelin, a widespread hormone: insights into molecular and cellular regulation of its expression and metabolism of action [Review]. FEBS Lett 2003;552:105-9.
65. Zigman JM, Elmquist JK. Minireview: from anorexia to obesity - the yin and yang of body weight control. Endocrinology 2003; 144:3749-56.
66. Holdstock C, Engstrom BE, Ohrvall M, Lind L, Sundbom M, Karlsson FA. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab 2003;88:3177-83.
67. Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 2000;276:905-8.
68. Shuto Y, Shibasaki T, Otagiri A, Kuriyama H, Ohala H, Tamura H, et al. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest 2002;109:1429-36.
69. Kalra SP, Kalra PS. Neuropeptide Y: a physiological orexigen modulated by the feedback action of ghrelin and leptin. Endocrine 2003;22:49-56.
70. Banks WA, Tschöp M, Robinson SM, Heiman ML. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 2002;302:822-7.
71. Gröschl M, Uhr M, Kraus T. Evaluation of the comparability of commercial ghrelin assays. Clin Chem 2004;50:457-8.
72. Soriano-Guillen L, Barrios V, Campos-Barros A, Argente J. Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J Pediatr 2004;144:30-5.
73. McLaughlin T, Abbasi F, Lamendola C, Frayo RS, Cummings DE. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J Clin Endocrinol Metab 2004;89:1630-5.
74. Misra M, Miller KK, Herzog DB, Ramaswamy K, Aggarwal A, Almazan C, et al. Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls. J Clin Endocrinol Metab 2004;89:1605-12.
75. Whatmore AJ, Hall CM, Jones J, Westwood M, Clayton PE. Ghrelin concentrations in healthy children and adolescents. Clin Endocrinol 2003;59:649-54.
76. Soriano-Guillen L, Barrios V, Lechuga-Sancho A, Chowen JA, Argente J. Response of circulating ghrelin levels to insulin therapy in children with newly diagnosed type I diabetes mellitus. Pediatr Res 2004;55:830-5.
77. Marzullo P, Verti B, Savia G, Walker GE, Guzzaloni G, Tagliaferri M, et al. the relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure. J Clin Endocrinol Metab 2004;89:936-9.
78. Malik IA, English PJ, Ghatei MA, Bloom SR, MacFarlane IA, Wilding JP. The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency. Clin Endocrinol 2004;60:137-41.
79. Wu JT, Kral JG. Ghrelin: integrative neuroendocrine peptide in health and disease. Ann Surg 2004;239:464-74.
80. Broglio F, Gottero C, Arvat E, Ghigo E. Endocrine and non-endocrine actions of ghrelin. Horm Res 2003;59:109-17.
81. Woods SC. Gastrointestinal satiety signals I. An overview of gastrointestinal signals that influence food intake. Am J Physiol Gastrointest Liver Physiol 2004;286:G7-13.
82. Ukkola O. Endocrinological activities of ghrelin: new insights. Eur J Intern Med 2003;14:351-6.
83. Berg AH, Combs TP, Scherer PE. ACRP 30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002;13:84-9.
84. Shapiro L, Scherer PE. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol 1998;12:335-8.
85. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, et al. Cloning of adiponectin receptors that mediate anti-diabetic metabolic effects. Nature 2003;423:762-9.
86. Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, Lodish HF. T-Cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci USA 2004; 101:10308-13.
87. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp 30 enhances hepatic insulin action. Nat Med 2001;7:947-53.
88. Tomas E, Tsao TS, Saha AK, Murrey HE, Zhang CC, Itani SL, et al. Enhanced muscle fat oxidation and glucose transport by ACRP 30 globular domain: acetyl CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA 2002;99:16309-13.
89. Faraj M, Havel PJ, Phelis S, Blanck D, Snideman AD, Cianflone K. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2003;88:1594-602.
90. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003;361:226-8.
91. Thamer C, Machann J, Tschritter O, Haap M, Wietek B, Haring HU, et al. Relationship between serum adiponectin concentration and intramyocellular lipid stores in humans. Horm Metab Res 2002;34:646-9.
92. Saltiel AR. You are what you secrete. Nat Med 2001;7:887-8.
93. Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K, Nagai R. Molecular mechanism of insulin resistance and obesity. Exp Biol Med 2003;228:1111-7.
94. Maeda N, Takahashi M, Fuhahashi T, Kihara S, Nishizawa H, Kishida K, et al. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001;50:2094-9.
95. Ruan H, Lodish HF. Insulin resistance in adipose tissue: direct and indirect effects of TNF-α. Cytokine Growth Factor Rev 2003; 14:447-55.
96. Stumvoll M. Thiazolidinediones - some recent developments. Expert Opin Investig Drugs 2003;12:1179-87.
97. Masaki T, Chiba S, Yasuda T, Tsubone T, Kakuma T, Shimomura I, et al. Peripheral, but not central, administration of adiponectin reduces visceral adiposity and upregulates the expression of uncoupling protein in agouti yellow (Ay/a) obese mice. Diabetes 2003;52:2266-73.
98. Hardie DG. Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 2003;144:5179-83.
99. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration prevents a decrease in wholebody insulin sensitivity in humans. Diabetes 2002;51:1884-8.
100. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adiposespecific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1565-9.
101. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida K, Matsuzawa Y, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002;277: 37487-91.
102. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Matsuzawa Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001;103:1057-63.
103. Kamada Y, Tamura S, Kiso S, Matsumoto H, Saji Y, Yoshida Y, et al. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 2003;125:1796-807.
104. Fernandez-Real JM, Lopez-Bermejo A, Casamitjina R, Ricart W. Novel interactions of adiponectin with the endocrine system and inflammatory parameters. J Endocrinol Metab 2003;88:2714-8.
105. Aldhahi W, Hamdy O. Adipokines, inflammation, and the endothelium in diabetes. Curr Diab Rep 2003;3:293-8.
106. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003;14:561-6.
107. Suominen P. Evaluation of an enzyme immunometric assay to measure serum adiponectin concentrations. Clin Chem 2004; 50:219-21.
108. Tagami T, Satoh N, Usui T, Yamada K, Shimatsu A, Kuzuya H. Adiponectin in anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 2004;89:1833-7.
109. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologica 2003;46:459-69.
110. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001;86:3815-9.
111. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-5.
112. Goldfine A, Kahn CR. Adiponectin: linking the fat cell to insulin sensitivity. Lancet 2003;362:1431-2.
113. Ravussin E, Smith SR. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci 2002;967:363-78.
114. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004; 24:29-33.
115. Dzielinska Z, Januszewicz A, Wiecek A, Demkow M, Makowiecka-Ciesla M, Ruzyllo W, et al. Decreased plasma concentration of a novel anti-inflammatory protein adiponectin in hypertensive men with coronary artery disease. Thromb Res 2003;110:365-9.
116. Aruna B, Ghosh S, Singh AK, Mande SC, Srinivas V, Chauhan R, et al. Human recombinant resistin protein displays a tendency to aggregate by forming intermolecular disulfide linkages. Biochemistry 2003;42:10554-9.
117. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, et al. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 2000;19:4046-55.
118. Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, et al. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 2001;98:502-6.
119. Rajala MW, Lin Y, Ranalletta M, Yang XM, Qian H, Gingerich R, et al. Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-α in adipose tissue. Mol Endocrinol 2002;16:1920-30.
120. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature 2001;409:307-12.
121. Flier JS. Diabetes: the missing link with obesity? Nature 2001; 409:292-3.
122. Ukkola O. Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander? Eur J Endocrinol 2002; 147:571-4.
123. Shuldiner AR, Yang R, Gong D-W. Resistin, obesity, and insulin resistance - the emerging role of the adipocyte as an endocrine organ. N Engl J Med 2001;345:1345-6.
124. Way JM, Gorgun CZ, TongQ, Uysal KT, Brown KK, Harrington WW, et al. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor γ agonists. J Biol Chem 2001;276:25651-3.
125. Moore GB, Chapman H, Holder JC, Lister CA, Piercy V, Smith SA, et al. Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice. Biochem Biophys Res Commun 2001; 286:735-41.
126. Le Lay SL, Boucher J, Rey A, Castan-Laurell I, Krief S, Ferre P, et al. Decreased resistin expression in mice with different sensitivities to a high-fat diet. Biochem Biophys Res Commun 2001; 289:564-7.
127. Hotamisligil G. The irresistible biology of resistin. J Clin Invest 2003;111:173-4.
128. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, et al. Resistin/FIZZ3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans. Diabetes 2001;50:2199-202.
129. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM. Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res 2002;10:1-5.
130. Gomez-Ambrosi J, Fruehbeck G. Do resistin and resistin-like molecules also link obesity to inflammatory diseases? Am Intern Med 2001;135:306-7.
131. Rajala MW, Obici S, Scherer PhE, Rosseth L. Adipose derived resistin and gut-derived resistin like molecule-β selectively impair insulin action on glucose protection. J Clin Invest 2003;111: 225-30.
132. Youn BS, Yu KY, Park HU, Lee NS, Min SS, Youn MY, et al. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab 2004;89:150-6.
133. Rea R, Donnelly R. Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity? Diabetes Obes Metab 2004; 6:163-70.
134. Stejskal D, Adamovska S, Bartek J, Jurakova R, Proskova J. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003;147: 63-9.
135. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Watson W, Kerr K, Jones R, et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 2003;88:5452-5.
136. Steppan CM, Lazar MA. The current biology of resistin. J Intern Med 2004;255:439-47.